AEMD
Aethlon Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.82
−5.70%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | — | — | — | — | 574.2K |
| Cost of Revenue | 388.0K | — | — | — | — |
| Gross Profit | (388.0K) | — | — | — | 574.2K |
| Operating Expenses | |||||
| R&D Expense | 1.4M | 1.9M | 2.2M | 2.5M | 2.7M |
| SG&A Expense | 5.9M | 7.3M | 9.3M | 12.6M | 12.5M |
| General & Admin Expense | 3.5M | 4.0M | 5.0M | 7.0M | 7.5M |
| Selling & Marketing Expense | — | 3.3M | 4.3M | 5.6M | 5.0M |
| Other Expenses | (669.5K) | (1.9M) | (2.2M) | (2.5M) | (2.7M) |
| Total Operating Expenses | 6.7M | 7.3M | 9.3M | 12.6M | 12.5M |
| Cost and Expenses | 7.1M | 7.3M | 9.3M | 12.6M | 12.5M |
| Operating Income (EBIT) | (7.1M) | (7.3M) | (9.3M) | (12.6M) | (11.9M) |
| Non-Operating | |||||
| Interest Income | 157.3K | 156.5K | 298.1K | 428.4K | 11.0K |
| Interest Expense | 14.4K | 14.4K | 10.1K | — | — |
| Net Interest Income | 142.9K | 142.2K | 288.0K | 428.4K | 11.0K |
| Other Non-Op Income/Expense | 142.9K | 142.2K | (4.0M) | 428.4K | (131.1K) |
| Non-Operating Income (excl Interest) | (97.9K) | (156.5K) | 4.0M | (428.4K) | 131.1K |
| EBT (Pre-Tax Income) | (6.9M) | (7.2M) | (13.4M) | (12.2M) | (12.0M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (6.9M) | (7.2M) | (13.4M) | (12.2M) | (12.0M) |
| Earnings from Cont. Ops | (6.9M) | (7.2M) | (13.4M) | (12.2M) | (12.0M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (6.9M) | (7.2M) | (13.4M) | (12.2M) | (12.0M) |
| Per Share | |||||
| Basic EPS | ($11.70) | ($10.61) | ($85.77) | ($388.67) | ($468.60) |
| Diluted EPS | ($11.70) | ($10.61) | ($85.77) | ($388.67) | ($468.60) |
| Revenue Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $22.97 |
| Shares | |||||
| Basic Shares Outstanding | 384705 | 673000 | 156000 | 31000 | 25000 |
| Diluted Shares Outstanding | 384705 | 673945 | 156085 | 31410 | 25672 |
| Profitability Metrics | |||||
| EBITDA | (6.5M) | (6.8M) | (13.0M) | (11.8M) | (11.8M) |
| D&A | 460.9K | 323.7K | 339.6K | 359.1K | 240.9K |
| EBIT | (7.0M) | (7.1M) | (13.4M) | (12.2M) | (12.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026